DK113641B - Fremgangsmåde til fremstilling af steroidketoner. - Google Patents

Fremgangsmåde til fremstilling af steroidketoner.

Info

Publication number
DK113641B
DK113641B DK448162AA DK448162A DK113641B DK 113641 B DK113641 B DK 113641B DK 448162A A DK448162A A DK 448162AA DK 448162 A DK448162 A DK 448162A DK 113641 B DK113641 B DK 113641B
Authority
DK
Denmark
Prior art keywords
production
steroid ketones
steroid
ketones
Prior art date
Application number
DK448162AA
Other languages
Danish (da)
English (en)
Inventor
G Hughes
H Smith
Original Assignee
H Smith
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to BE651797D priority Critical patent/BE651797A/xx
Application filed by H Smith filed Critical H Smith
Priority to GB4001667A priority patent/GB1100443A/en
Priority to GB4001767A priority patent/GB1100444A/en
Priority to IL2182664A priority patent/IL21826A/en
Priority to NO15427664A priority patent/NO126016B/no
Priority to IN95058A priority patent/IN95058B/en
Priority to DE19641793641 priority patent/DE1793641C2/de
Priority to BR16164364A priority patent/BR6461643D0/pt
Priority to DE19641468988 priority patent/DE1468988B1/de
Priority to DE19641618871 priority patent/DE1618871C3/de
Priority to DE19641618872 priority patent/DE1618872C3/de
Priority to CH1052964A priority patent/CH498819A/de
Priority to CH1742068A priority patent/CH498820A/de
Priority to CH381370A priority patent/CH499510A/de
Priority to CH1742168A priority patent/CH498821A/de
Priority to CH1387870A priority patent/CH507225A/de
Priority to FR1566154D priority patent/FR1566154A/fr
Priority to DK400464A priority patent/DK134161B/da
Priority to AT292768A priority patent/AT301039B/de
Priority to AT227470A priority patent/AT301045B/de
Priority to AT696964A priority patent/AT269376B/de
Priority to SE983464A priority patent/SE331470B/xx
Priority to SE843170A priority patent/SE350256B/xx
Priority to NL6409391A priority patent/NL139307B/xx
Priority to FR994684A priority patent/FR4915M/fr
Priority to NO16575366A priority patent/NO127193B/no
Priority to NO16575266A priority patent/NO132762C/no
Priority to SE04238/68A priority patent/SE335120B/xx
Priority to SE04239/68A priority patent/SE334879B/xx
Priority to SE04237/68A priority patent/SE335119B/xx
Publication of DK113641B publication Critical patent/DK113641B/da
Priority to DK655269A priority patent/DK127598B/da
Priority to JP5758471A priority patent/JPS4837029B1/ja
Priority to DK395771A priority patent/DK132031C/da
Priority to NO495971A priority patent/NO129905B/no
Priority to DK220272A priority patent/DK127475B/da
Priority to DK38273A priority patent/DK131020B/da
Priority to DK84773A priority patent/DK131367B/da
Priority to DK286173A priority patent/DK134264B/da
Priority to NL7308508A priority patent/NL7308508A/xx
Priority to NL737308507A priority patent/NL145559B/xx
Priority to IN137555A priority patent/IN137555B/en
Priority to IN1000/CAL/74A priority patent/IN137556B/en
Priority to IN1001/CAL/74A priority patent/IN137557B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A43—FOOTWEAR
    • A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
    • A43B3/00—Footwear characterised by the shape or the use
    • A43B3/12—Sandals; Strap guides thereon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Woven Fabrics (AREA)
  • Manufacturing Of Printed Wiring (AREA)
  • Phenolic Resins Or Amino Resins (AREA)
DK448162AA 1961-10-19 1962-10-17 Fremgangsmåde til fremstilling af steroidketoner. DK113641B (da)

Priority Applications (43)

Application Number Priority Date Filing Date Title
BE651797D BE651797A (en:Method) 1962-10-17
GB4001667A GB1100443A (en) 1962-10-17 1963-08-14 17ª‡-chloroethynyl-13ª‰-ethylgonenolone
GB4001767A GB1100444A (en) 1962-10-17 1963-08-14 13-alkyl 17-halogenoalkynyl steroid 3-alcohols and their esters
IL2182664A IL21826A (en) 1962-10-17 1964-08-03 Steroid ketones and their derivatives
NO15427664A NO126016B (en:Method) 1962-10-17 1964-08-05
IN95058A IN95058B (en:Method) 1962-10-17 1964-08-05
DE19641618871 DE1618871C3 (de) 1962-10-17 1964-08-10 Verfahren zur Herstellung eines Steroidketonderivates. Ausscheidung aus: 1468988
BR16164364A BR6461643D0 (pt) 1962-10-17 1964-08-10 Processo de preparacao de cetonas esteroides e seus derivados
DE19641468988 DE1468988B1 (de) 1962-10-17 1964-08-10 17alpha-Chloraethinyl-13beta-aethyl-4- oder -5(10)-gonen-3-ketone
DE19641793641 DE1793641C2 (de) 1962-10-17 1964-08-10 Verfahren zur Herstellung von 17-Halogenalkinyl 3-ketogonen und deren Verwendung. Ausscheidung aus: 1468988
DE19641618872 DE1618872C3 (de) 1962-10-17 1964-08-10 Verfahren zur Herstellung von 13-Äthylgonanverbindungen und gewisse 13-Äthylgonanverbindungen. Ausscheidung aus: 1468988
CH381370A CH499510A (de) 1962-10-17 1964-08-12 Verfahren zur Herstellung von Steroidketonderivaten mit 17-oder 17a-Halogenalkinylgruppen
CH1742068A CH498820A (de) 1961-10-19 1964-08-12 Verfahren zur Herstellung von Steroidketonderivaten mit 17- oder 17a-Halogenalkinylgruppen
CH1052964A CH498819A (de) 1962-10-17 1964-08-12 Verfahren zur Herstellung von Steroidketonen mit 17- oder 17a-Halogenalkinylgruppen
CH1742168A CH498821A (de) 1962-10-17 1964-08-12 Verfahren zur Herstellung von Steroidketonderivaten mit 17- und 17a-Halogenalkinylgruppen
CH1387870A CH507225A (de) 1962-10-17 1964-08-12 Verfahren zur Herstellung von Steroidketonen mit 17- oder 17a-Halogenalkinylgruppen
FR1566154D FR1566154A (en:Method) 1962-10-17 1964-08-13
DK400464A DK134161B (da) 1962-10-17 1964-08-13 Analogifremgangsmåde til fremstilling af steroidketoner.
AT292768A AT301039B (de) 1962-10-17 1964-08-13 Verfahren zur Herstellung von neuen Steroiden
AT227470A AT301045B (de) 1962-10-17 1964-08-13 Verfahren zur Herstellung von neuen Steroiden
AT696964A AT269376B (de) 1962-10-17 1964-08-13 Verfahren zur Herstellung von neuen Steroidketonen
SE983464A SE331470B (en:Method) 1962-10-17 1964-08-14
NL6409391A NL139307B (nl) 1962-10-17 1964-08-14 Werkwijze voor het bereiden van een geneesmiddel met een hormoonactiviteit.
SE843170A SE350256B (en:Method) 1962-10-17 1964-08-14
FR994684A FR4915M (en:Method) 1962-10-17 1964-11-12
NO16575366A NO127193B (en:Method) 1962-10-17 1966-11-25
NO16575266A NO132762C (en:Method) 1962-10-17 1966-11-25
SE04238/68A SE335120B (en:Method) 1962-10-17 1968-03-29
SE04239/68A SE334879B (en:Method) 1962-10-17 1968-03-29
SE04237/68A SE335119B (en:Method) 1962-10-17 1968-03-29
DK655269A DK127598B (da) 1962-10-17 1969-12-10 Analogifremgangsmåde til fremstilling af 17-halogenalkynyl-3,17-dihydroxy-13-ethylgonener eller -D-homogener eller estere eller ethere deraf.
JP5758471A JPS4837029B1 (en:Method) 1962-10-17 1971-08-02
DK395771A DK132031C (da) 1962-10-17 1971-08-12 Analogifremgangsmade til fremstilling af 17-haloalkynyl-17-hydroxy-13-ethyl-gonen-3-oner eller de tilsvarende d-homo-forbindelser
NO495971A NO129905B (en:Method) 1962-10-17 1971-12-30
DK220272A DK127475B (da) 1962-10-17 1972-05-03 Analogifremgangsmåde til fremstilling af17-halogenalkynyl-17-hydroxy-13-ethylgonener eller -D-homogonener eller estere eller ethere deraf.
DK38273A DK131020B (da) 1962-10-17 1973-01-24 Antikonceptionelt middel.
DK84773A DK131367B (da) 1962-10-17 1973-02-16 Antikonceptionelt middel.
DK286173A DK134264B (da) 1962-10-17 1973-05-24 Antikonceptionelt middel.
NL7308508A NL7308508A (en:Method) 1962-10-17 1973-06-19
NL737308507A NL145559B (nl) 1962-10-17 1973-06-19 Werkwijze voor het bereiden van een preparaat met progestatieve en anti-oestrogene activiteit, gevormd geneesmiddel en werkwijze voor het bereiden van progestatieve en anti-oestrogeen actieve verbindingen.
IN137555A IN137555B (en:Method) 1962-10-17 1974-05-03
IN1000/CAL/74A IN137556B (en:Method) 1962-10-17 1974-05-03
IN1001/CAL/74A IN137557B (en:Method) 1962-10-17 1974-05-03

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB37618/61A GB1041279A (en) 1961-10-19 1961-10-19 13-alkyl steroid ketones

Publications (1)

Publication Number Publication Date
DK113641B true DK113641B (da) 1969-04-14

Family

ID=10397775

Family Applications (6)

Application Number Title Priority Date Filing Date
DK448162AA DK113641B (da) 1961-10-19 1962-10-17 Fremgangsmåde til fremstilling af steroidketoner.
DK449762AA DK115621B (da) 1961-10-19 1962-10-18 Fremgangsmåde til fremstilling af umættede steroidketoner.
DK449662AA DK115549B (da) 1961-10-19 1962-10-18 Fremgangsmåde til fremstilling af umættede steroidketoner.
DK449562AA DK121228B (da) 1961-10-19 1962-10-18 Analogifremgangsmåde til fremstilling af umættede steroidketoner.
DK227069AA DK129652B (da) 1961-10-19 1969-04-24 17-Carbonhydrid-substituerede 3,17-dihydroxy-13-alkyl-gonener til anvendelse som mellemprodukter ved fremstilling af farmakologisk aktive, tilsvarende 17-carbonhydrid-substituerede 3-oxo-17-hydroxy-13-alkyl-gon-4- eller -5(10)-ener.
DK339670AA DK124753B (da) 1961-10-19 1970-06-30 Analogifremgangsmåde til fremstilling af 13-alkyl-gonen-3,17-dioler.

Family Applications After (5)

Application Number Title Priority Date Filing Date
DK449762AA DK115621B (da) 1961-10-19 1962-10-18 Fremgangsmåde til fremstilling af umættede steroidketoner.
DK449662AA DK115549B (da) 1961-10-19 1962-10-18 Fremgangsmåde til fremstilling af umættede steroidketoner.
DK449562AA DK121228B (da) 1961-10-19 1962-10-18 Analogifremgangsmåde til fremstilling af umættede steroidketoner.
DK227069AA DK129652B (da) 1961-10-19 1969-04-24 17-Carbonhydrid-substituerede 3,17-dihydroxy-13-alkyl-gonener til anvendelse som mellemprodukter ved fremstilling af farmakologisk aktive, tilsvarende 17-carbonhydrid-substituerede 3-oxo-17-hydroxy-13-alkyl-gon-4- eller -5(10)-ener.
DK339670AA DK124753B (da) 1961-10-19 1970-06-30 Analogifremgangsmåde til fremstilling af 13-alkyl-gonen-3,17-dioler.

Country Status (12)

Country Link
AT (4) AT264730B (en:Method)
CH (5) CH450407A (en:Method)
CY (1) CY429A (en:Method)
DE (4) DE1617818B2 (en:Method)
DK (6) DK113641B (en:Method)
ES (1) ES281669A1 (en:Method)
FI (4) FI41025B (en:Method)
FR (1) FR2796M (en:Method)
GB (2) GB1041279A (en:Method)
MY (1) MY6800075A (en:Method)
NO (4) NO122645B (en:Method)
SE (6) SE335526B (en:Method)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2636404C2 (de) * 1976-08-12 1983-12-08 Schering AG, 1000 Berlin und 4709 Bergkamen Δ↑1↑↑5↑-17α-Äthinylsteroide der Östranreihe, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Präparate
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
CN104926906B (zh) * 2015-06-04 2016-02-10 保定北瑞甾体生物有限公司 一种17α-羟基黄体酮的制备方法

Also Published As

Publication number Publication date
CH450408A (de) 1968-01-31
DE1468604C2 (de) 1971-03-04
DK129652B (da) 1974-11-04
CH450407A (de) 1968-01-31
DK129652C (en:Method) 1975-04-07
DE1793595A1 (de) 1972-02-03
FI41025B (en:Method) 1969-04-30
SE313809B (en:Method) 1969-08-25
DK115621B (da) 1969-10-27
FI41024B (en:Method) 1969-04-30
AT256354B (de) 1967-08-25
DE1618855B2 (de) 1973-04-05
CH459195A (de) 1968-07-15
FI41026B (en:Method) 1969-04-30
SE340619B (en:Method) 1971-11-29
SE312552B (en:Method) 1969-07-21
MY6800075A (en) 1968-12-31
DE1468604B1 (de) 1970-07-02
SE335526B (en:Method) 1971-06-01
DE1617818B2 (de) 1976-12-09
CH455763A (de) 1968-05-15
DK115549B (da) 1969-10-20
NO122645B (en:Method) 1971-07-26
CY429A (en) 1968-01-15
DK124753B (da) 1972-11-20
SE312551B (en:Method) 1969-07-21
DE1793608B1 (de) 1972-05-04
DE1618855C3 (en:Method) 1973-10-25
GB1041279A (en) 1966-09-01
AT256356B (de) 1967-08-25
NO122644B (en:Method) 1971-07-26
FR2796M (fr) 1964-09-21
NO122646B (en:Method) 1971-07-26
AT264730B (de) 1968-09-10
NO122643B (en:Method) 1971-07-26
CH432509A (de) 1967-03-31
ES281669A1 (es) 1963-03-16
GB1041278A (en) 1966-09-01
FI41027B (en:Method) 1969-04-30
DK121228B (da) 1971-09-27
DE1618855A1 (de) 1972-05-18
SE312553B (en:Method) 1969-07-21
DE1617818A1 (de) 1972-05-18
AT256355B (de) 1967-08-25
DE1793595B2 (de) 1975-10-30

Similar Documents

Publication Publication Date Title
DK104168C (da) Fremgangsmåde til fremstilling af mono-biguanider.
DK118242B (da) Fremgangsmåde til fremstilling af anhydropenicilliner.
DK108976C (da) Fremgangsmåde til fremstilling af hendecapeptider.
DK107027C (da) Fremgangsmåde til fremstilling af 3-hydroxy-benzisoxazoler.
DK108455C (da) Fremgangsmåde til fremstilling af i 5-stillingen usubstituerede 2-amino-benzophenoner.
DK113641B (da) Fremgangsmåde til fremstilling af steroidketoner.
DK134161B (da) Analogifremgangsmåde til fremstilling af steroidketoner.
DK106184C (da) Fremgangsmåde til fremstilling af alkylaralkylftalater.
DK118082B (da) Fremgangsmåde til fremstilling af 4-cyanthiazol.
DK111322B (da) Fremgangsmåde til fremstilling af DL-ribose.
DK108188C (da) Fremgangsmåde til fremstilling af trichlorethylen.
DK104055C (da) Fremgangsmåde til fremstilling af 6-methoxytetraloner.
DK104136C (da) Fremgangsmåde til fremstilling af benzensulfonylsemicarbazider.
DK104347C (da) Fremgangsmåde til fremstilling af 16α-hydroxysteroider.
DK104622C (da) Fremgangsmåde til fremstilling af 3-N-substituerede cyclohexenonderivater.
DK105152C (da) Fremgangsmåde til fremstilling af L-methionin.
DK99050C (da) Fremgangsmåde til fremstilling af uranium-aluminiumlegeringer.
DK105270C (da) Fremgangsmåde til fremstilling af betamethason.
DK102292C (da) Fremgangsmåde til fremstilling af 17α-hydroxy-20-keto-16β-methyl-steroider.
DK104625C (da) Fremgangsmåde til fremstilling af estrogener.
DK94989C (da) Fremgangsmåde til fremstilling af umættede ketoner.
DK88967C (da) Fremgangsmåde til fremstilling af umættede ketoner.
DK105411C (da) Fremgangsmåde til fremstilling af 5-alkoxy-2-sulfanilylaminopyrimidiner.
DK101054C (da) Fremgangsmåde til fremstilling af N-kvaternære O-benzylaminoalkyl-N-phenylurethaner.
DK102131C (da) Fremgangsmåde til fremstilling af 2-glycylamido-benzophenoner.